Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc.

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

Release Date: July 31, 2019
Expiration Date: July 31, 2020
Media: Internet - based

Activity Overview

This continuing medical education (CME)-certified online activity, “Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma,” is an online interactive monograph that provides an overview of etiologic factors in hepatocellular carcinoma (HCC), the implications of a growing understanding of pathophysiologic considerations as they relate to diagnosis and treatment, and treatment options available for HCC. Arndt Vogel, MD, PhD, discusses current and emerging treatment options for the treatment of HCC, emphasizes the keys to managing adverse events (AEs), and provides strategies to ensure the provision of timely and effective sequencing of therapy to optimize patient outcomes.

Benefits of Participating

Upon successful completion of this educational program, you should be better prepared to:

  • Outline advancements in treatment strategies for patients with HCC
  • Evaluate clinical data on efficacy and safety supporting the use of novel treatments, and make informed decisions to optimize clinical outcomes of patients with HCC
  • Educate patients about the disease, treatments, and treatment-related AEs
  • Facilitate the enrollment of patients with HCC in clinical trials that are testing novel therapies for the management and treatment of HCC

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, educational content/video files will be available for your reference.
  • In order to receive a CME/CE certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward an international audience of medical oncologists who treat or manage patients with HCC. Nurse practitioners, nurses, physician assistants, and other healthcare professionals involved in the treatment and management of patients with HCC are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the etiologic factors in HCC and the implications of a growing understanding of these pathophysiologic considerations as they relate to diagnosis and treatment.
  • Detail the biologic and mechanistic rationales underlying the use of tyrosine kinase inhibitors, checkpoint inhibitors, and other treatment modalities in HCC.
  • Review efficacy and safety data from the latest practice-changing clinical trials in HCC.
  • Indicate appropriate treatment strategies in HCC to ensure the provision of timely and effective sequencing of therapy to optimize patient outcomes.

Faculty, Staff, and Planners’ Disclosures

Faculty

Arndt Vogel
Arndt Vogel, MD, PhD
Managing Senior Consultant of Gastroenterology Oncology
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Disclosures: Consultant: Roche, Lilly, BMS, MSD, AstraZeneca, Eisai, BTG; Speakers Bureau: Roche, Lilly, BMS, AstraZeneca, EISAI, BTG.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or any of the companies that provided commercial support for this program.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
25262728293031
Filter By